Form 4: Unity Biotechnology Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Alexander Hieu Nguyen, CLO and Head of Operations at Unity Biotechnology, sold 164 shares of common stock to cover tax withholding obligations.
Summary
- On February 4, 2025, Alexander Hieu Nguyen, CLO and Head of Operations at Unity Biotechnology, sold 164 shares of common stock at a price of $2.23 per share.
- The sale was executed pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Nguyen directly owns 24,559 shares of Unity Biotechnology, which includes RSUs that vest over time from the grant date.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing reflects a routine transaction for tax purposes and doesn't indicate any significant change in the executive's outlook on the company.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This sale appears to be routine, covering tax obligations related to equity compensation.
Stakeholder Impact
- The sale of a small number of shares is unlikely to have a significant impact on shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/04/2025 | Date of stock sale transaction. |
| 02/05/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.